STRW logo

STRAWBERRY FIELDS REIT INC

STRWNYSE AMERICAN
πŸ† #3052 by market capEarnings Nov 5US Equity
$602.29β–Ό $46.68 (βˆ’7.75%)
Simulated price
1hβ€”
24hβ–Ό 7.8%
7dβ€”
14dβ€”
30dβ€”
1yβ€”
🏦Market Cap
$193M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+6.5%
Slowing
πŸ“ŠGross Margin
84.9%
High
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
1.2x
Cheap
Otter Score
46
Weak
No chart data available for STRW.

Trading Snapshot

Day Range
$592.94 – $609.03
52-Week Range
$10.08 – $14.75
Volume
$6.25B
Avg Volume
$6.30B
Shares Outstanding
13.4M
Next Earnings
Sep 9, 2026

Fundamentals Snapshot

Annual Revenue
$155M
Last Q Revenue
$40M
P/E Ratio
23.4
P/S Ratio
1.2x
EPS (TTM)
$0.64
Dividend Yield
4.17%

Why Investors Own STRW

  • βœ“High-growth profile β€” revenue up +10.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 31% gross margin and 17% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$155Mβ–² +7.5% YoY
Gross Margin (TTM)
30.7%β–Ό βˆ’0.5% YoY
Operating Income (TTM)
$31Mβ–² +7.5% YoY
Free Cash Flow (TTM)
$26Mβ–² +7.5% YoY

About STRAWBERRY FIELDS REIT INC

Strawberry Fields REIT, Inc., is a self-administered real estate investment trust engaged in the ownership, acquisition, development and leasing of skilled nursing and certain other healthcare-related properties. The Company’s portfolio includes 143 healthcare facilities with an aggregate of 15,600+ beds, located throughout the states of Arkansas, Illinois, Indiana, Kansas, Kentucky, Missouri, Ohio, Oklahoma, Tennessee and Texas. The 143 healthcare facilities comprise 131 skilled nursing facilities, 10 assisted living facilities, and two long-term acute care hospitals. Strawberry Fields REIT, Inc. was incorporated in 2019 in Maryland, USA.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
46/100

Analyst Price Target

β“˜
Average Target
$722.27
β–² +19.9% Upside
High Target$884.39
Low Target$570.89
Based on 28 analysts

Latest News & Updates